SIRT6 is reduced by proteasome-mediated degradation via ubiquitination in the hepatocyte cytoplasm when NAFL progresses to NASH in NAFLD patients compared to healthy individuals (65, 75). This evidence concerns the gene SIRT6 and metabolic dysfunction-associated steatotic liver disease.